MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5009/gnl250605

Медицинская библиотека · Gut and liver · 2026

Sex Differences in Growth Recovery among Children with Crohn's Disease.

Kim Dong-Uk, Moon Jin Soo, Lee Yeoun Joo, Choe Yon Ho, Lim Hyeji, Shin Minsoo, Kim Soon Chul, Yang Hye Ran, Ryoo Eell, Lee Yoo Min, Park Ji-Sook, Kang Ki Soo, Kim Tae Hyeong, Oh Seak Hee, Kang Ben, Choi So Yoon, Lee Yoon, Chang Ju Young, Ko Jae Sung, Shim Jung Ok

СтатьяПеревод в очереди

Аннотация

BACKGROUND/AIMS: Growth impairment remains a major concern in pediatric Crohn's disease (pCD) patients, yet long-term growth trajectories and sex-specific treatment responses have not been adequately characterized.

METHODS

This study investigated 2-year growth trajectories and determinants of catch-up growth from a nationwide registry in Korea. Growth outcomes were analyzed in 533 children with pCD using multivariable linear regression and generalized additive models (GAM).

RESULTS

At diagnosis, 16.1% and 4.1% of patients had weight-for-age and height-for-age z-scores less than -2, respectively. Weight recovery was more readily achieved than linear growth during follow-up (median z-score change: 0.61, p<0.001 vs -0.01, p=0.582). Females presented with lower baseline weight z-scores than males (-1.00 vs -0.63; p=0.001) but displayed superior weight recovery (0.81 vs 0.51; p<0.001) and significant height recovery (0.09 vs -0.08 in males; p<0.001). In the multivariable analysis, the baseline weight z-score, platelet count, albumin, and disease activity predicted weight recovery (R²=26.3%), while the baseline height z-score was the strongest predictor of height recovery. The GAM analysis suggested that infliximab use was associated with enhanced height recovery (β=0.104, p=0.045), with benefits observed primarily in females aged <14 years (β=0.339, p=0.044).

CONCLUSIONS

This Asian cohort study with the largest population to date demonstrates that weight recovery precedes linear growth, with females showing superior catch-up. Notably, our findings highlight a selective association between infliximab treatment and height recovery in females younger than 14 years, suggesting sex- and age-specific differences in the treatment response that warrant further investigation. (Clinical trial registration: Korea Clinical Research Information Service KCT0008723).

Для цитирования: Kim Dong-Uk, Moon Jin Soo, Lee Yeoun Joo, Choe Yon Ho, Lim Hyeji, Shin Minsoo, Kim Soon Chul, Yang Hye Ran, Ryoo Eell, Lee Yoo Min, Park Ji-Sook, Kang Ki Soo, Kim Tae Hyeong, Oh Seak Hee, Kang Ben, Choi So Yoon, Lee Yoon, Chang Ju Young, Ko Jae Sung, Shim Jung Ok. Sex Differences in Growth Recovery among Children with Crohn's Disease.. Gut and liver. 2026. DOI: 10.5009/gnl250605.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.